ATE226194T1 - 1-acryloylindolin-derivate und ihre verwendung als prodrugs von antikrebsmittel - Google Patents
1-acryloylindolin-derivate und ihre verwendung als prodrugs von antikrebsmittelInfo
- Publication number
- ATE226194T1 ATE226194T1 AT97948036T AT97948036T ATE226194T1 AT E226194 T1 ATE226194 T1 AT E226194T1 AT 97948036 T AT97948036 T AT 97948036T AT 97948036 T AT97948036 T AT 97948036T AT E226194 T1 ATE226194 T1 AT E226194T1
- Authority
- AT
- Austria
- Prior art keywords
- acryloylindoline
- derivatives
- prodrugs
- anticancer prodrugs
- prodrug therapy
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 3
- 239000000651 prodrug Substances 0.000 title abstract 3
- MBODXUXQQPORNR-UHFFFAOYSA-N 1-(2,3-dihydroindol-1-yl)prop-2-en-1-one Chemical class C1=CC=C2N(C(=O)C=C)CCC2=C1 MBODXUXQQPORNR-UHFFFAOYSA-N 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 238000010914 gene-directed enzyme pro-drug therapy Methods 0.000 abstract 2
- INCAQIRDTKGRNM-UHFFFAOYSA-N 2-cyclopropyl-1h-indole Chemical class C1CC1C1=CC2=CC=CC=C2N1 INCAQIRDTKGRNM-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 235000018734 Sambucus australis Nutrition 0.000 abstract 1
- 244000180577 Sambucus australis Species 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9625913.0A GB9625913D0 (en) | 1996-12-13 | 1996-12-13 | Novel cyclopropylindoles and their seco precursors,and their use as prodrugs |
| PCT/NZ1997/000166 WO1998025898A1 (en) | 1996-12-13 | 1997-12-12 | Seco precursors of cyclopropylindolines and their use as prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226194T1 true ATE226194T1 (de) | 2002-11-15 |
Family
ID=10804392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97948036T ATE226194T1 (de) | 1996-12-13 | 1997-12-12 | 1-acryloylindolin-derivate und ihre verwendung als prodrugs von antikrebsmittel |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0944596B1 (de) |
| JP (1) | JP2001506623A (de) |
| AT (1) | ATE226194T1 (de) |
| AU (1) | AU728053B2 (de) |
| CA (1) | CA2272952A1 (de) |
| DE (1) | DE69716463T2 (de) |
| DK (1) | DK0944596T3 (de) |
| ES (1) | ES2186006T3 (de) |
| GB (1) | GB9625913D0 (de) |
| NZ (1) | NZ335841A (de) |
| PT (1) | PT944596E (de) |
| WO (1) | WO1998025898A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9909612D0 (en) * | 1999-04-26 | 1999-06-23 | Cancer Res Campaign Tech | N-protected amines and their use as prodrugs |
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| EP2344478B1 (de) | 2008-11-03 | 2017-09-27 | Syntarga B.V. | Cc-1065 analoga und ihre konjugate |
| SG10201501272SA (en) * | 2009-10-22 | 2015-04-29 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
| EP2560645B1 (de) | 2010-04-21 | 2016-07-13 | Syntarga B.V. | Konjugate von cc-1065 analoga und bifunktionellen linkern |
| PL3092010T3 (pl) | 2014-01-10 | 2019-01-31 | Synthon Biopharmaceuticals B.V. | Sposób oczyszczania połączonych cysteiną koniugatów przeciwciało-lek |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1238907A (en) * | 1984-02-21 | 1988-07-05 | Robert C. Kelly | 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds |
| GB8705477D0 (en) * | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| US5214065A (en) * | 1990-06-11 | 1993-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Dc-89 derivatives |
| US5258383A (en) * | 1991-06-28 | 1993-11-02 | Kyowa Hakko Kogyo Co., Ltd. | DC-89 derivatives |
-
1996
- 1996-12-13 GB GBGB9625913.0A patent/GB9625913D0/en active Pending
-
1997
- 1997-12-12 AU AU54192/98A patent/AU728053B2/en not_active Ceased
- 1997-12-12 CA CA002272952A patent/CA2272952A1/en not_active Abandoned
- 1997-12-12 ES ES97948036T patent/ES2186006T3/es not_active Expired - Lifetime
- 1997-12-12 WO PCT/NZ1997/000166 patent/WO1998025898A1/en not_active Ceased
- 1997-12-12 NZ NZ335841A patent/NZ335841A/xx unknown
- 1997-12-12 PT PT97948036T patent/PT944596E/pt unknown
- 1997-12-12 EP EP97948036A patent/EP0944596B1/de not_active Expired - Lifetime
- 1997-12-12 DK DK97948036T patent/DK0944596T3/da active
- 1997-12-12 AT AT97948036T patent/ATE226194T1/de not_active IP Right Cessation
- 1997-12-12 DE DE69716463T patent/DE69716463T2/de not_active Expired - Fee Related
- 1997-12-12 JP JP52653298A patent/JP2001506623A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0944596A1 (de) | 1999-09-29 |
| JP2001506623A (ja) | 2001-05-22 |
| ES2186006T3 (es) | 2003-05-01 |
| CA2272952A1 (en) | 1998-06-18 |
| DK0944596T3 (da) | 2002-12-16 |
| PT944596E (pt) | 2003-03-31 |
| GB9625913D0 (en) | 1997-01-29 |
| EP0944596B1 (de) | 2002-10-16 |
| WO1998025898A1 (en) | 1998-06-18 |
| AU728053B2 (en) | 2001-01-04 |
| DE69716463T2 (de) | 2003-06-05 |
| AU5419298A (en) | 1998-07-03 |
| DE69716463D1 (de) | 2002-11-21 |
| NZ335841A (en) | 2000-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9402342D0 (en) | Phosphono-oxymethyl-ethers of taxane derivatives | |
| DE69530606D1 (de) | Verwendung von pramipexole als neuroschutzmittel | |
| DE69807074D1 (de) | Substituierte 1,2,4-triazolo[3,4,-a]phthalazin-derivate als gaba-alpha 5-liganden | |
| ATE248824T1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
| IL88531A (en) | Cognitive enhancing compositions containing d-cycloserine | |
| ATE156858T1 (de) | Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung | |
| FI970150A0 (fi) | Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö | |
| NL1002835A1 (nl) | Synergistisch stabilisatormengsel. | |
| ATE26835T1 (de) | Tris(piperidylaminotriazylamino) verbindungen, ihre herstellung und ihre verwendung als stabilisierungsmittel fuer polymere. | |
| FI955643A0 (fi) | N-alkyylitiopolyaminnijohdannaiset säteilyltä suojaavina aineina | |
| FI925988A0 (fi) | Foerfarande foer framstaellning av b-laktamer | |
| PT1028950E (pt) | Quinazolina-2,4-dionas 7-substituidas uteis como agentes antibacterianos | |
| ATE220679T1 (de) | Porphyrine und ihre verwendung als photosensitizer | |
| ATE226194T1 (de) | 1-acryloylindolin-derivate und ihre verwendung als prodrugs von antikrebsmittel | |
| TR200000174T2 (tr) | Bir poliorganosiloksana bağlı bir bağlayıcı içeren titanyum partiküllerinin (lakuna) dağılımı. | |
| ATE228980T1 (de) | Verwendung von alkoholen als additive für putze und/oder mörtel | |
| ES2099879T3 (es) | 5-oxo-dibenzo(a,d)ciclohepta-1,4-dienos y su uso como agentes retrovirales. | |
| DE69433856D1 (de) | C10 Taxan Derivate und pharmazeutische Zusammensetzungen | |
| ES2104174T3 (es) | Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos. | |
| MX9705738A (es) | Compuestos de hule que contienen acidos aril-bis-citraconamicos. | |
| ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| CA2206104A1 (en) | Adamantyl substituted oxindoles as pharmaceuticals agents | |
| SU1584356A1 (ru) | ПЕРФТОРАЛКИЛЗАМЕЩЕННЫЕ β,β'-ДИКЕТОЭФИРАТЫ ТРЕХВАЛЕНТНОГО ЖЕЛЕЗА КАК КАТАЛИЗАТОРЫ РЕАКЦИИ ОБРАЗОВАНИЯ ПОЛИУРЕТАНОВ | |
| GT199300023A (es) | Derivados de aminoacidos | |
| MX9708155A (es) | Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0944596 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |